KembaliKembaliDiluted net income available to common stockholders dari Keros Therapeutics, Inc..
Data tahunan
−200,00 M
−150,00 M
−100,00 M
−50,00 M
0,00
Periode
Nilai
Perubahan
% Perubahan
TTM
−181,57 M
−28,58 M
−18,68%
2023
−152,99 M
−48,31 M
−46,15%
2022
−104,68 M
−45,94 M
−78,20%
2021
−58,74 M
−13,38 M
−29,50%
2020
−45,36 M
−31,23 M
−220,89%
2019
−14,14 M
−11,79 M
−502,56%
Data per kuartal
Q2 '19
Q3 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−60,00 M
−45,00 M
−30,00 M
−15,00 M
0,00
Periode
Nilai
Perubahan
% Perubahan
Q3 '24
−52,96 M
−7,70 M
−17,01%
Q2 '24
−45,26 M
−2,14 M
−4,97%
Q1 '24
−43,11 M
−2,87 M
−7,13%
Q4 '23
−40,24 M
−803,00 K
−2,04%
Q3 '23
−39,44 M
−1,94 M
−5,16%
Q2 '23
−37,51 M
−1,70 M
−4,75%
Q1 '23
−35,80 M
−6,09 M
−20,48%
Q4 '22
−29,72 M
−6,21 M
−26,41%